Histopathological evaluation of skin in cirrhotic patients with pruritus

Document Type : Original Article

Authors

1 DERMATOLOGY, Venereology and Andrology, Faculty of Medicine , sohag university.

2 Department of Dermatology, Venereology and Andrology, Sohag Faculty of Medicine, Sohag University.

3 Departments of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University.

4 Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Sohag University.

5 Department of pathology, Assuit Faculty of Medicine, Assuit University.

Abstract

Background: Cirrhosis often is a silent disease Clinical symptoms at presentation may include jaundice of the eyes or skin, pruritus, gastrointestinal bleeding, coagulopathy, increasing abdominal girth, and mental status changes. Pruritus may be the presenting symptom, arising years before any other classic clinical and laboratory markers of hepatic dysfunction. This study examines the clinical, laboratory and histopathological changes in the skins of cirrhotic patients with pruritus in comparison with cirrhotic patients without pruritus and healthy control skins .
Patients and Methods: To evaluate  clinical, laboratory and histopathological changes in cirrhotic patients with pruritus, cirrhotic patients without pruritus  and corresponding healthy (control). skin biopsies (20 specimens each) using hematoxylin and eosin stain and to study mast cell density using gimesa stain.
Results: In the skin biopsy specimens of the cirrhotic patients with pruritus we found several histological changes including: epidermal hyperplasia (acanthosis) ,vascular ectasia(dilated dermal blood vessels), hypertrophied dermal nerve endings, mixed inflammatory cellular infilterate and lymphocytic vasculopathy (swelling of the endothelial cell lining of the blood vessels without fibrinoid necrosis, leucocytoclasia or extravasation of red blood cells). Evaluation of mast cell count in Gimesa stained skin sections revealed an  increased  numbers of these cells in the group of cirrhotic patients with pruritus ( N=5-10). The cells noted in perivascular, perineural and interstitial distribution (between collagen bundles).
Conclusions: We report, for the first time, some histopathologial  changes in the skins of cirrhotic patients with pruritus in comparison with cirrhotic patients without pruritus and healthy control skins .

  1. Malekzadeh R, Mohamadnejad M, Rakhshani N, Nasseri-Moghaddam  S, Merat S, Tavangar SM, et al (2004): Reversibility of cirrhosis in chronic hepatitis B. Clin Gastroenterol Hepatol;2:344-7.
  2. Heidelbaugh J and Sherbondy M (2006). Cirrhosis and chronic liver failure. Part II: Complications and treatment. Am Fam Physician;74:765-74,779.
  3. Diehl A. Alcoholic and nonalcoholic steatohepatitis. Goldman L,Ausiello D (2004), eds. Cecil Textbook of Medicine. 22nd ed. Philadelphia, Pa.: Saunders,:935-6.
  4. Amin M, Shahat M, El-Garem N, Soliman A, Obaia E (2017): Assessment of serum level cholinesterase as a biomarker of liver cirrhosis in Egyptian cirrhotic patients Gastroenterology Insights; volume 8:6914
  5. Rosselli M and Zuckermann M (2011). Liver cirrhosis. Best Pract Res Clin Gastroenterol.;25:281–290.
  6. Jones D (2012): Pathogenesis of cholestatic itch: old questions, new answers, and future opportunities. Hepatology.;56(4):1194-6.
  7. Bergasa N (2005): The pruritus of cholestasis. J Hepatol.;43(6): 1078-88.
  8. Bergasa N (2011): The itch of liver disease. Semin. Cutan. Med. Surg30: 93– 8             
  9. Mela A, Mancuso A, Burroughs AK (2003): Review article: pruritus in cholestasis and other liver diseases. Aliment Pharmacol Ther.;17(7):857-70.
  10. Beuers U, Kremer AE, Bolier R, Elferink RP (2014):Pruritus in cholestasis: facts and fiction. Hepatology.;60(1):399-407.
  11. Metz M and Ständer S (2010): Chronic pruritus – pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venerol.;24(11):1249-60.
  12. Paus R, Theoharides TC, Arck PC (2006):Neuroimmune endocrine circuitry of the ‘‘brain-skin connection’’.Trends Immunol 15:1–13
  13. Kremer AE, Elferink RP, Beuers U (2011): Pathophysiology and current management of pruritud in liver disease. Clin Res Hepatol Gastroenterol.;35:89-97
  14. European Association for the study of the liver (2009): EASL Clinical Practice guidelines: Management of liver diseases. J Hepatol.;51(2):237-40.
  15. Dawson P and Karpen S (2014):Bile acids reach out to the spinal cord: new insights to the pathogenesis of itch and analgesia in cholestatic liver disease. Hepatology. ;59:1638–41.
  16. Khalil S, Youssef M, Mekkawy M, Abdelmalek M (2015): Liver Cirrhosis: Impact Of Nutritional Regimen On Patients Outcome. IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-ISSN: 2320–1959.p- ISSN: 2320–1940 Volume 4, Issue 2 Ver. III (Mar.-Apr. 2015), PP 22-35.
  17. O’Keefee C, Baird AW, Nolan N, Mccomick PA (2004):Cholestatic pruritus: the role of cutaneous mast cells and nerves. Aliment Pharmacol Ther.;19(12):1293-300.
  18. Lindor K, Gershwin M, Poupon R, Kaplan M, Bergasa N, Heathcote E (2009): American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology.;50(1):291-308.